ClinConnect ClinConnect Logo
Search / Trial NCT06595927

Clinical Signs and Changes in Cervical Muscles Activity Evaluated by Magnetic Resonance Imaging During an Endurance Test

Launched by DAVID COLMAN · Sep 10, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how neck muscles behave during a specific endurance test, particularly looking at differences between people with chronic neck pain and those without any neck issues. Researchers will use advanced imaging technology to see how well the neck can support the head and how muscles react during this test. The goal is to understand the connection between muscle activity and neck strength, which could help improve treatments for neck pain.

To take part in this study, you should be between the ages of 18 and 75 and meet certain criteria: if you have neck pain, your disability score should be above 8 out of 50, and your pain level should be less than 7 out of 10. If you do not have any neck pain, your score should be below 4 out of 50, and you should not have needed any medical treatment for neck pain in the past year. Participants will undergo some tests but will not be actively recruited just yet, as the study is still in the planning phase. This research could provide valuable insights into the causes of neck pain and how to better manage it in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Neck Disability Index score \> 8/50 for the symptomatic group OR \< 4/50 for the asymptomatic group
  • numerical rating scale \< 7/10 for the symptomatic group
  • suffering from idiopathic or traumatic chronic neck pain for the neck pain group OR being free of neck pain which required therapeutic, medical or medicinal treatment in the last 12 months.
  • Exclusion Criteria:
  • fibromyalgia, cervical radiculopathy, previous cervical surgery

About David Colman

David Colman is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the pharmaceutical and biotechnology sectors, he focuses on the development of innovative therapies across various therapeutic areas. David Colman’s approach emphasizes rigorous scientific methodologies, ethical standards, and collaboration with leading researchers and institutions. By fostering a culture of transparency and accountability, he aims to accelerate the translation of groundbreaking discoveries into effective treatment options for patients in need.

Locations

Liège, , Belgium

Patients applied

0 patients applied

Trial Officials

Marc MV Vanderthommen, Professor

Study Chair

University of Liege

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported